Clinical research progress of efficacy and safety of Remazolam in painless gastroenteroscopy
SHEN Yue1 LU Hongxiu2
1.The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250014, China;
2.Department of Anesthesiology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Shandong Province, Jinan 250014, China
Abstract：At present, Remimazolam is being widely used as a new benzodiazepine sedative in painless gastroenteroscopy. Compared with commonly used sedative drugs such as Propofol and Midazolam, it is still unknown to a certain extent whether its sedative effect is superior and its safety is higher, and further clinical verification is needed. This review of PubMed and CNKI studies on Remimazolam applied to painless gastroenteroscopy find that Remimazolam has significant sedative effect, guaranteed comfort, less adverse reactions to circulation system, respiratory system, and cognitive function, and is used in combination with analgesics, especially alfentanil, during painless procedures to reduce the risk of respiratory depression.
申越1 鹿洪秀2. 瑞马唑仑在无痛胃肠镜中的有效性及安全性的临床研究进展[J]. 中国医药导报, 2023, 20(21): 54-57.
SHEN Yue1 LU Hongxiu2. Clinical research progress of efficacy and safety of Remazolam in painless gastroenteroscopy. 中国医药导报, 2023, 20(21): 54-57.
[1] 陈念平，仇元利，宋铖，等.瑞马唑仑或丙泊酚联合纳布啡用于无痛胃肠镜麻醉的对照研究[J].全科医学临床与教育，2022，20（12）：1085-1088.
[2] 张俊伟，胡艳辉，李之明.环泊酚在无痛胃肠镜麻醉中的应用研究[J].中国现代药物应用，2022，16（16）：35-38.
[3] Doi M，Hirata N，Suzuki T，et al. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients （ASA class Ⅲ）：results of a multicenter，randomized，double-blind，parallel-group comparative trial [J]. J Anesth，2020，34（4）：491-501.
[4] 罗俊杰，占乐云，覃兆军.瑞马唑仑在老年患者中的临床研究进展[J].临床医学研究与实践，2022，7（32）：192-194.
[5] Lee A，Shirley M. Remimazolam：a review in procedural sedation [J]. Drugs，2021，81（10）：1193-1201.
[6] Oka S，Satomi H，Sekino R，et al. Sedation outcomes for remimazolam，a new benzodiazepine [J]. J Oral Sci，2021，63（3）：209-211.
[7] Zheng X，Ji J，Cheng H，et al. Efficacy and safety of different doses of remimazolam tosylate for colonoscopy：single-center，prospective，randomized，double-blind，parallel trial [J]. Ann Transl Med，2022，10（22）：1244.
[8] 钟琳，梁建华，何颖宜，等.甲苯磺酸瑞马唑仑、丙泊酚和依托咪酯用于高龄高血压患者无痛胃镜的效果比较[J].心血管病防治知识，2021，11（21）：34-38.
[9] Pastis NJ，Yarmus LB，Schippers F，et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy [J]. Chest，2019，155（1）：137-146.
[10] 何江，付宝军，叶艳霞，等.瑞马唑仑在肝硬化患者无痛胃镜检查中的应用[J].今日药学，2022，32（8）：618-622.
[11] 朱伟波，于建民，王建越，等.不同剂量甲苯磺酸瑞马唑仑对经肠道内镜黏膜下剥离术者抗感染效果分析[J].临床和实验医学杂志，2022，21（22）：2462-2465.
[12] Zhu X，Wang H，Yuan S，et al. Efficacy and safety of remimazolam in endoscopic sedation-a systematic review and meta-analysis [J]. Front Med（Lausanne），2021，8：655042.
[13] Qiu Y，Gu W，Zhao M，et al. The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection：a randomized trial [J]. Front Med（Lausanne），2022，9：938940.
[14] Wang X，Hu X，Bai N，et al. Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy：a multicentre，single-blind，randomized，controlled，phase Ⅲ trial [J]. Front Pharmacol，2022，13：900723.
[15] Lu C，Ren J，Guo X，et al. Effects of remimazolam combined with esketamine anesthesia on circulatory and respiratory function during painless gastroenteroscopy [J]. Contrast Media Mol Imaging，2022，2022：1079099.
[16] Chen SH，Yuan TM，Zhang J，et al. Remimazolam tosilate in upper gastrointestinal endoscopy：a multicenter，randomized，non-inferiority，phase Ⅲ trial [J]. J Gastroenterol Hepatol，2021，36（2）：474-481.
[17] Hu B，Jiang K，Shi W，et al. Effect of remimazolam tosilate on respiratory depression in elderly patients undergoing gastroscopy：a multicentered，prospective，and randomized study [J]. Drug Des Devel Ther，2022，16：4151-4159.
[18] Chen S，Wang J，Xu X，et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy：a multicentered，randomized，positive-controlled，phase Ⅲ clinical trial [J]. Am J Transl Res，2020，12（8）：4594-4603.
[19] Rex DK，Bhandari R，Desta T，et al. A phase Ⅲ study evaluating the efficacy and safety of remimazolam （CNS 7056） compared with placebo and midazolam in patients undergoing colonoscopy [J]. Gastrointest Endosc，2018，88（3）：427-437.
[20] Rex DK，Bhandari R，Lorch DG，et al. Safety and efficacy of remimazolam in high risk colonoscopy：a randomized trial [J]. Dig Liver Dis，2021，53（1）：94-101.
[21] Tan Y，Ouyang W，Tang Y，et al. Effect of remimazolam tosilate on early cognitive function in elderly patients undergoing upper gastrointestinal endoscopy [J]. J Gastroenterol Hep- atol，2022，37（3）：576-583.
[22] Xin Y，Chu T，Wang J，et al. Sedative effect of remimazolam combined with alfentanil in colonoscopic polypectomy：a prospective，randomized，controlled clinical trial [J]. BMC Anesthesiol，2022，22（1）：262.
[23] Zhou J，Leonowens C，Ivaturi V D，et al. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects [J].J Clin Anesth，2020，66：109899.
[24] Goudra B，Gouda G，Mohinder P. Recent developments in drugs for GI endoscopy sedation [J]. Dig Dis Sci，2020，65（10）：2781-2788.
[25] Chen X，Sang N，Song K，et al. Psychomotor recovery following remimazolam-induced sedation and the effectiveness of flumazenil as an antidote [J]. Clin Ther，2020，42（4）：614-624.
[26] Gotoda T，Akamatsu T，Abe S，et al. Guidelines for sedation in gastroenterological endoscopy （second edition） [J]. Dig Endosc，2021，33（1）：21-53.
[27] Ichijima R，Ikehara H，Maeda T，et al. First dose-ranging study of remimazolam in Japanese patients undergoing gastrointestinal endoscopy：phase Ⅱ investigator-initiated clinical trial [J]. Dig Endosc，2022，34（7）：1403-1412.
[28] Pambianco DJ，Borkett KM，Riff DS，et al. A phase Ⅱb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy [J]. Gastrointest Endosc，2016，83（5）：984-992.
[29] Guo J，Qian Y，Zhang X，et al. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients：a prospective，randomized and controlled study [J]. BMC Anesthesiol，2022，22（1）：180.
[30] 马漪洁，张玉，陈占军,等.苯磺酸瑞马唑仑用于病态肥胖患者无痛胃镜检查的效果[J].河南外科学杂志，2022， 28（3）：60-62.
[31] Wang H，Gao X，Wei W，et al. The optimum sevoflurane concentration for supraglottic airway device Blockbuster? insertion with spontaneous breathing in obese patients：a prospective observational study [J]. BMC Anesthesiol，2017， 17（1）：156.
[32] Antonik LJ，Goldwater DR，Kilpatrick GJ，et al. A placebo- and midazolam-controlled phase Ⅰ single ascending-dose study evaluating the safety，pharmacokinetics，and pharmacodynamics of remimazolam （CNS 7056）：Part Ⅰ. Safety，efficacy，and basic pharmacokinetics [J]. Anesth Analg，2012， 115（2）：274-283.
[33] Chae D，Kim HC，Song Y，et al. Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia：a randomised，prospective，double-blind study [J]. Br J Anaesth，2022，129 （1）：49-57.
[34] 陈瑾，马红，刘美玉.瑞马唑仑复合瑞芬太尼用于无痛胃镜检查的半数有效剂量[J].临床麻醉学杂志，2021， 37（9）：953-956.
[35] 陈弟，赵唐圆梦，徐志新,等.瑞马唑仑复合布托啡诺抑制老年患者胃镜检查置入反应的半数有效剂量[J].临床麻醉学杂志，2022，38（6）：663-665.
[36] 杨少杰，余旻，舒爱华,等.复合瑞马唑仑时阿芬太尼用于无痛胃镜检查的半数有效剂量[J].临床麻醉学杂志，2022，38（12）：1330-1332.
[37] 张雯，沈淼.苯磺酸瑞马唑仑联合阿芬太尼用于无痛胃肠镜患者的双盲对照研究[J].中国医院药学杂志，2023， 43（1）：61-64.
京公网安备 11010502046598号